Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Breast Cancer Research and Treatment|May 17, 2008
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, U Dafni, M A Dimopoulos, et al.
Oncology|March 1, 1996
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyG Fountzilas, A Polichronis, K Katsohis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerT Brodowicz, T Ciuleanu, J Crawford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2005
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, H P Kalofonos, U Dafni, et al.
Anticancer Research|March 12, 1998
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, S Vasilaros, D Koukouras, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in GreeceS Manolakou, N Tsoukalas, E Saloustros, et al.
ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.
Pageof 15